← United States · Coverage record
US · SEC FORM 4
GeneDx Holdings Corp.
WGS · Nasdaq · CIK 0001818331 · Healthcare · Diagnostics & Research
INSIDER SIGNAL
2 buyers · 24 purchase transaction lines · $93.1M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase activity is becoming less recent
- ✓ Role scores high · most senior buyer: Director,TenPercentOwner
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 69.4
- 69.3
- 69.3
- 69.3
- 69.3
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -19.8%
- 3M
- +5.5%
- 6M
- +12.9%
- 12M
- -45.1%
Volatility & liquidity
- Volatility
- 98.8%
- Beta
- —
- Avg daily value
- USD 49.2M
Valuation
- Market cap
- USD 2.0B
- P/E
- —
Fundamentals
- Profit margin
- -4.9%
- ROE
- -6.8%
- Industry
- Diagnostics & Research
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-27 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 5,626,310
- Previous report
- 5,884,765
- Avg daily volume
- 945,488
- Days to cover
- 6.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 50,000 | USD 52.86 | USD 2,643,000 | SEC filing ↗ |
| 2026-06-04 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 150,000 | USD 56.44 | USD 8,466,000 | SEC filing ↗ |
| 2026-05-20 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 140,000 | USD 43.81 | USD 6,133,400 | SEC filing ↗ |
| 2026-05-19 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 185,000 | USD 42.60 | USD 7,881,000 | SEC filing ↗ |
| 2026-05-18 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 175,000 | USD 42.55 | USD 7,446,250 | SEC filing ↗ |
| 2026-05-15 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 46,273 | USD 38.91 | USD 1,800,571 | SEC filing ↗ |
| 2026-05-14 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 140,000 | USD 39.39 | USD 5,514,790 | SEC filing ↗ |
| 2026-05-13 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 165,000 | USD 39.09 | USD 6,449,983 | SEC filing ↗ |
| 2026-05-11 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 500,000 | USD 39.29 | USD 19,642,789 | SEC filing ↗ |
| 2026-05-08 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 171,389 | USD 40.59 | USD 6,956,751 | SEC filing ↗ |
| 2026-05-07 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 533,758 | USD 37.86 | USD 20,207,189 | SEC filing ↗ |
| 2026-03-05 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 140,026 | USD 81.19 | USD 11,369,152 | SEC filing ↗ |
| 2026-03-03 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 29,495 | USD 70.89 | USD 2,090,937 | SEC filing ↗ |
| 2025-05-14 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 50,000 | USD 60.16 | USD 3,007,997 | SEC filing ↗ |
| 2025-05-08 | Corvex Management LP; Meister Keith A. | Purchase (P) | Class A Common Stock | 100,000 | USD 56.01 | USD 5,600,994 | SEC filing ↗ |
Form 4 evidence
184 transaction lines in the latest 365-day window; 737 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | Option exercise / conversion (M) | Class A Common Stock | 1,146 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-16 | Stueland Katherine | Sale (S) | Class A Common Stock | 10,501 | USD 97.61 | USD 1,025,031 | SEC filing ↗ |
| 2026-09-16 | Stueland Katherine | Option exercise / conversion (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | Option exercise / conversion (M) | Class A Common Stock | 1,146 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-16 | Stueland Katherine | Sale (S) | Class A Common Stock | 10,501 | USD 97.61 | USD 1,025,031 | SEC filing ↗ |
| 2026-09-16 | Stueland Katherine | Option exercise / conversion (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-16 | Feeley Kevin | Sale (S) | Class A Common Stock | 3,728 | USD 97.61 | USD 363,898 | SEC filing ↗ |
| 2026-09-16 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 7,197 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-09 | Stueland Katherine | Sale (S) | Class A Common Stock | 3,692 | USD 84.22 | USD 310,940 | SEC filing ↗ |
| 2026-09-09 | Stueland Katherine | Option exercise / conversion (M) | Class A Common Stock | 6,547 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-09 | Feeley Kevin | Sale (S) | Class A Common Stock | 1,285 | USD 84.22 | USD 108,223 | SEC filing ↗ |
| 2026-09-09 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 2,462 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-09-01 | Feeley Kevin | Sale (S) | Class A Common Stock | 372 | USD 83.84 | USD 31,188 | SEC filing ↗ |
| 2026-09-01 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 717 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | Ryan Jason | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | RUCH JOSHUA | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | PFENNIGER RICHARD C JR | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | Meister Keith A. | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | Leproust Emily M. | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-18 | Casdin Eli | Option exercise / conversion (M) | Class A Common Stock | 3,576 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Stueland Katherine | Sale (S) | Class A Common Stock | 10,501 | USD 60.76 | USD 638,092 | SEC filing ↗ |
| 2026-06-16 | Stueland Katherine | Option exercise / conversion (M) | Class A Common Stock | 18,750 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-16 | Feeley Kevin | Sale (S) | Class A Common Stock | 3,729 | USD 60.76 | USD 226,592 | SEC filing ↗ |
| 2026-06-16 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 7,197 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-09 | Stueland Katherine | Sale (S) | Class A Common Stock | 3,639 | USD 53.77 | USD 195,669 | SEC filing ↗ |
| 2026-06-09 | Stueland Katherine | Option exercise / conversion (M) | Class A Common Stock | 6,546 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-09 | Feeley Kevin | Sale (S) | Class A Common Stock | 1,266 | USD 53.77 | USD 68,073 | SEC filing ↗ |
| 2026-06-09 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 2,462 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 50,000 | USD 52.86 | USD 2,643,000 | SEC filing ↗ |
| 2026-06-04 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 150,000 | USD 56.44 | USD 8,466,000 | SEC filing ↗ |
| 2026-06-01 | Feeley Kevin | Sale (S) | Class A Common Stock | 369 | USD 51.74 | USD 19,092 | SEC filing ↗ |
| 2026-06-01 | Feeley Kevin | Option exercise / conversion (M) | Class A Common Stock | 717 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-20 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | Purchase (P) | Class A Common Stock, par value $0.0001 per share | 140,000 | USD 43.81 | USD 6,133,400 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | WGS |
| CIK | 0001818331 |
| Sector | Healthcare |
| Industry | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8000 Services-Health Services |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 737 transaction lines from 2021-07-22 to 2026-09-17 68 P purchase lines · 395 S sale lines · 274 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.